GEEFomjebuik: Gut Health Enhancement by Eating Favourable Food

Sponsor
VU University of Amsterdam (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05900609
Collaborator
Wageningen University and Research (Other), Maag Lever Darm Stichting (Other), Cidrani (Other), WholeFiber (Other), Keep Food Simple (Other)
147
1
3
6
24.4

Study Details

Study Description

Brief Summary

Within the GEEF om je buik study the effect of 8 weeks intervention with either a diet rich in fiber or fermented food on the gut microbiota will be investigated.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: WholeFiber
  • Dietary Supplement: Kombucha
  • Dietary Supplement: Maltodextrin DE19/21
N/A

Detailed Description

This study is a randomized controlled trial (RCT) with three intervention groups (high dietary fiber group (HDF), high fermented foods group (HFF), and a control group (CG)). The total duration of the study is 5 months and consists of an 8-week intervention ( 2-week ramp up period with dietary guidelines, followed by 6-week period with dietary guidelines + additional consumption of study products) and a follow-up after 3 months. In total 147 subjects will be included.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
147 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The study applies a randomized, parallel design of 8 weeks (+ follow-up after 3 months)The study applies a randomized, parallel design of 8 weeks (+ follow-up after 3 months)
Masking:
None (Open Label)
Masking Description:
This study is partially blinded, study participants in the fiber and fermented group will be informed about their intervention after randomization. However, the control group will remain blind throughout the intervention period. Furthermore, participants are not made aware of the different types of intervention before start or during the intervention period. This is done to prevent any adjustments of their diets based on the advices in the other groups and to ensure that the control group stays blinded.
Primary Purpose:
Prevention
Official Title:
Gut Health Enhancement by Eating Favourable Food
Anticipated Study Start Date :
Jun 15, 2023
Anticipated Primary Completion Date :
Dec 15, 2023
Anticipated Study Completion Date :
Dec 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fiber arm

Subjects receive dietary guidelines, to increase their fiber intake. Additionally, during the last 6 weeks of the intervention period subjects receive a study product containing 8,5 grams fiber per day. Additionally, subjects receive general guidelines about the effect of nutrition on the gut microbiome.

Dietary Supplement: WholeFiber
WholeFiberTM is a product with high levels of prebiotic dietary fibers (~85%) mainly consisting of inulin, and some pectin, hemi-cellulose and cellulose that is derived from the root vegetable, chicory roots. Fiber guidelines: Subjects receive a booklet with recipes high in fiber. Subjects are recommended to use 2 recipes per day + a snack. Estimated average intake via the recipes in the recipe booklet is 24 grams/day. General guidelines on nutrition and microbiome: Subjects receive a link to a website with general recommendations to positively alter the gut microbiome (website Voedingscentrum and Dutch Digestive Foundation).
Other Names:
  • Chicory roots
  • Experimental: Fermented food arm

    Subjects receive dietary guidelines, to increase their intake of fermented foods. Additionally, during the last 6 weeks of the intervention period subjects receive a study product of 17 millilitres concentrated kombucha per day. Additionally, subjects receive general guidelines about the effect of nutrition on the gut microbiome.

    Dietary Supplement: Kombucha
    The kombucha is produced by a minimum three-month long fermentation process. It is a live fermented herbal drink essence, without refined sugar, and an unpasteurized, organic product. Fermented food guidelines: Study participants in the fermented foods arm are asked to use 3 additional servings of fermented food per day, using the fermented food list / recipe booklet. General guidelines on nutrition and microbiome: Subjects receive a link to a website with general recommendations to positively alter the gut microbiome (website Voedingscentrum and Dutch Digestive Foundation).
    Other Names:
  • Fermented tea
  • Placebo Comparator: Control

    Subjects receive general guidelines about the effect of nutrition on the gut microbiome. Additionally, during the last 6 weeks of the intervention period subjects receive a placebo product of 10 grams maltodextrin per day.

    Dietary Supplement: Maltodextrin DE19/21
    Maltodextrin DE19/21 is a digestible carbohydrate, that is completely digested and does not reach the colon, which makes it a suitable placebo dietary compound and the reason why it is frequently used in comparable studies. General guidelines on nutrition and microbiome: Subjects receive a link to a website with general recommendations to positively alter the gut microbiome (website Voedingscentrum and Dutch Digestive Foundation).

    Outcome Measures

    Primary Outcome Measures

    1. Microbiota diversity [Baseline (week 0)]

      Microbioal richness (ASV) using 16s rRNA

    2. Microbiota diversity [End ramp-up (week 2)]

      Microbioal richness (ASV) using 16s rRNA

    3. Microbiota diversity [End intervention (week 8)]

      Microbioal richness (ASV) using 16s rRNA

    Secondary Outcome Measures

    1. Gut microbiota composition [Baseline (week 0)]

      16s rRNA

    2. Gut microbiota composition [End ramp-up (week 2)]

      16s rRNA

    3. Gut microbiota composition [End intervention (week 8)]

      16s rRNA

    4. Carbohydrate Active Enzymes (CAZymes) [Baseline (week 0)]

      Relative abundance of CAZymes using shotgun metagenomic sequencing

    5. Carbohydrate Active Enzymes (CAZymes) [End ramp-up (week 2)]

      Relative abundance of CAZymes using shotgun metagenomic sequencing

    6. Carbohydrate Active Enzymes (CAZymes) [End intervention (week 8)]

      Relative abundance of CAZymes using shotgun metagenomic sequencing

    7. 92 inflammatory serum proteins [Baseline (week 0)]

      92 immune markers, including circulating cytokine levels, cell-specific cytokine response signaling, and cell frequency and immune cell signaling at steady-state, measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX).

    8. 92 inflammatory serum proteins [End ramp-up (week 2)]

      92 immune markers, including circulating cytokine levels, cell-specific cytokine response signaling, and cell frequency and immune cell signaling at steady-state, measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX).

    9. 92 inflammatory serum proteins [End intervention (week 8)]

      92 immune markers, including circulating cytokine levels, cell-specific cytokine response signaling, and cell frequency and immune cell signaling at steady-state, measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX).

    10. Dietary intake [Baseline (week 0)]

      Average intake of fiber, fermented foods and macronutrients using the Traqq app

    11. Dietary intake [End ramp-up (week 2)]

      Average intake of fiber, fermented foods and macronutrients using the Traqq app

    12. Dietary intake [End intervention (week 8)]

      Average intake of fiber, fermented foods and macronutrients using the Traqq app

    13. Dietary intake [End follow-up (5 months)]

      Average intake of fiber, fermented foods and macronutrients using the Traqq app

    14. Gastrointestinal complaints [Daily during intervention (week 0 - week 8)]

      Likert-point scale (scores 0 - 10), for bloating, flatulence and abdominal pain. A higher score means more bloating, flatulence and abdominal pain.

    15. Stool frequency [Daily during intervention (week 0 - week 8)]

      Frequency of bowel movement per day

    16. Stool consistency [Daily during intervention (week 0 - week 8)]

      Consistency per stool, based on Bristol Stool Score (type 1 -7)

    17. Abundance of Prevotella [Baseline (week 0)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    18. Abundance of Prevotella [End ramp-up (week 2)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    19. Abundance of Prevotella [End intervention (week 8)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    20. Abundance of Bacteroides [Baseline (week 0)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    21. Abundance of Bacteroides [End ramp-up (week 2)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    22. Abundance of Bacteroides [End intervention (week 8)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    23. Ratio of Prevotella/Bacteroides [Baseline (week 0)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    24. Ratio of Prevotella/Bacteroides [End ramp-up (week 2)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    25. Ratio of Prevotella/Bacteroides [End intervention (week 8)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    26. Microbial alpha diversity [Baseline (week 0)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    27. Microbial alpha diversity [End ramp-up (week 2)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    28. Microbial alpha diversity [End intervention (week 8)]

      Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning).

    29. Transit time [Baseline (week 0)]

      Using blue dye method (two blue muffins)

    30. Transit time [End ramp-up (week 2)]

      Using blue dye method (two blue muffins)

    31. Transit time [End intervention (week 8)]

      Using blue dye method (two blue muffins)

    32. Sleep quality [Baseline (week 0)]

      Athens insomnia scale. Score range: 0-28 points. Higher score means worse outcome.

    33. Sleep quality [End ramp-up (week 2)]

      Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality.

    34. Sleep quality [End intervention (week 8)]

      Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality.

    35. Sleep quality [End follow-up (5 months)]

      Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality.

    36. Digestion associated Quality of Life [Baseline (week 0)]

      Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life.

    37. Digestion associated Quality of Life [End ramp-up (week 2)]

      Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life.

    38. Digestion associated Quality of Life [End intervention (week 8)]

      Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life.

    39. Digestion associated Quality of Life [End follow-up (5 months)]

      Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life.

    40. Well-being [Baseline (week 0)]

      World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being.

    41. Well-being [End ramp-up (week 2)]

      World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being.

    42. Well-being [End intervention (week 8)]

      World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being.

    43. Well-being [End follow-up (5 months)]

      World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being.

    44. Subjective health (perception and awareness) [Baseline (week 0)]

      A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health

    45. Subjective health (perception and awareness) [End intervention (week 8)]

      A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health

    46. Subjective health (perception and awareness) [End follow-up (5 months)]

      A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health

    47. Intention to stay healthy (perception + awareness) [Baseline (week 0)]

      A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy

    48. Intention to stay healthy (perception + awareness) [End intervention (week 8)]

      A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy

    49. Intention to stay healthy (perception + awareness) [End follow-up (5 months)]

      A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy

    50. Dietary intrinsic motivation (perception + awareness) [Baseline (week 0)]

      A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation.

    51. Dietary intrinsic motivation (perception + awareness) [End intervention (week 8)]

      A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation.

    52. Dietary intrinsic motivation (perception + awareness) [End follow-up (5 months)]

      A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation.

    53. Dietary self-efficacy (perception + awareness) [Baseline (week 0)]

      A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy

    54. Dietary self-efficacy (perception + awareness) [End intervention (week 8)]

      A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy

    55. Dietary self-efficacy (perception + awareness) [End follow-up (5 months)]

      A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy

    56. Self-regulation (perception + awareness) [Baseline (week 0)]

      A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation

    57. Self-regulation (perception + awareness) [End intervention (week 8)]

      A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation

    58. Self-regulation (perception + awareness) [End follow-up (5 months)]

      A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation

    59. Subjective knowledge (perception + awareness) [Baseline (week 0)]

      A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge

    60. Subjective knowledge (perception + awareness) [End intervention (week 8)]

      A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge

    61. Subjective knowledge (perception + awareness) [End follow-up (5 months)]

      A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge

    Other Outcome Measures

    1. Body Mass Index (BMI) [Baseline (week 0)]

      Weight and height will be combined to report BMI in kg/m^2

    2. Body Mass Index (BMI) [End ramp-up (week 2)]

      Weight and height will be combined to report BMI in kg/m^2

    3. Body Mass Index (BMI) [End intervention (week 8)]

      Weight and height will be combined to report BMI in kg/m^2

    4. Body Mass Index (BMI) [End follow-up (5 months)]

      Weight and height will be combined to report BMI in kg/m^2

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Men and Women, aged ≥18 - ≤70 years;

    • Being able to read and speak Dutch;

    • Willing to keep a stable dietary pattern throughout the study, apart from the dietary advice in the study;

    • Having a smartphone compatible with the Lifedata or PocketQ app to fill out the daily questionnaires.

    Exclusion Criteria:
    • Having a disease or medical condition which can influence the study results such as diabetes, cancer, diagnosed irritable bowel syndrome, renal disease, liver enzyme abnormality, malignant neoplasm, or a history of inflammatory diseases (such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease);

    • Having a history of intestinal surgery that might interfere with study outcomes (this does not include an appendectomy or cholecystectomy);

    • Average dietary fiber intake of ≥18 gram (women) or ≥22 gram (men) per day, according to the fiber screen questionnaire (see F1 questionnaires);

    • More than 3 servings of fermented foods per day as assessed with the fermented food frequency questionnaire (see F1 questionnaires);

    • Having a Body Mass Index (BMI) of ≥ 30 kg/m2 (self-reported);

    • Currently following a strict diet and unwilling or unable to change; for example, a gluten free diet or a "crash diet" using meal substitutes;

    • Specific food allergies that interfere with dietary intervention (for example, gluten, lactose, etc);

    • Use of prebiotics, probiotics and/or synbiotics (this should be stopped 4 weeks before the start of the study) and use of fiber supplements;

    • Use of antibiotic treatment less than 3 months before start of the study and/or use of antibiotics during the study;

    • Use of medication that can interfere with the study outcomes, as judged by the medical supervisor;

    • Alcoholic use of ≥14 (women) or ≥28 (men) glasses of alcoholic beverages per week;

    • Use of soft or hard drugs (should be stopped at least 4 weeks before start of the study);

    • Being pregnant or lactating;

    • Participation in another clinical trial at the same time;

    • Student or employee working at either Food, Health and Consumer Research from Wageningen Food and Biobased Research, Microbiology at VU, the MLDS, at WholeFiber, Keep Food Simple or at Cidrani;

    • Unable to follow or comply to study rules.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stichting Wageningen Research Wageningen Gelderland Netherlands 6708 WG

    Sponsors and Collaborators

    • VU University of Amsterdam
    • Wageningen University and Research
    • Maag Lever Darm Stichting
    • Cidrani
    • WholeFiber
    • Keep Food Simple

    Investigators

    • Principal Investigator: Nicole de Wit, PhD, Wageningen Food and Biobased Research
    • Principal Investigator: Remco Kort, PhD, VU University of Amsterdam

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Remco Kort, Professor doctor, VU University of Amsterdam
    ClinicalTrials.gov Identifier:
    NCT05900609
    Other Study ID Numbers:
    • NL83652.028.23
    First Posted:
    Jun 12, 2023
    Last Update Posted:
    Jun 12, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Remco Kort, Professor doctor, VU University of Amsterdam
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 12, 2023